Rapamycin-sensitive signals control TCR/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation.
about
mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and agingOxidative stress in the pathology and treatment of systemic lupus erythematosusThe transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infectionmTOR Links Environmental Signals to T Cell Fate Decisions.Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccinesmTOR and lymphocyte metabolism.Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development.Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.Rapamycin restores p14, p15 and p57 expression and inhibits the mTOR/p70S6K pathway in acute lymphoblastic leukemia cells.Activation of TGF-β-induced non-Smad signaling pathways during Th17 differentiation.Inappropriate costimulation and aberrant DNA methylation as therapeutic targets in angioimmunoblastic T-cell lymphoma.Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft-versus-host disease control.An Autocrine TNFα-Tumor Necrosis Factor Receptor 2 Loop Promotes Epigenetic Effects Inducing Human Treg Stability In Vitro.
P2860
Q28081442-774B947C-AF03-432E-AEA4-84753CAF0F3BQ33715508-4880CFE9-C283-4F04-A275-24512FDBF91AQ34734469-6ABC3369-23A7-4148-8206-C8C4C539E7C7Q34986648-B31B5197-AB18-47E9-BEAA-DBF1EC542996Q35876220-3B0D9367-4BB6-4726-BACD-A4C5AD47BC0EQ37137525-4722D055-49B4-45D4-8BF1-E799CBC79A36Q37353724-4F96B23C-C9F0-4B28-B9FA-85D77493D6A9Q37649641-553EFEC5-44D8-4C27-A51F-2D0DF49C0BA5Q38835910-D00A42AB-06F6-43E0-BBD2-9BB426712600Q41139083-E9E4F1DA-175C-4806-B66C-F8620F2009D7Q42322772-A82F00CD-3763-42F1-9B30-E60E7B7DF46CQ53166890-99276EF8-6A7B-467A-B088-8946B4BCD825Q55027907-77CA9FBB-4694-4471-BF05-FA9F48466D46
P2860
Rapamycin-sensitive signals control TCR/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Rapamycin-sensitive signals co ...... d promoter region methylation.
@ast
Rapamycin-sensitive signals co ...... d promoter region methylation.
@en
Rapamycin-sensitive signals co ...... d promoter region methylation.
@nl
type
label
Rapamycin-sensitive signals co ...... d promoter region methylation.
@ast
Rapamycin-sensitive signals co ...... d promoter region methylation.
@en
Rapamycin-sensitive signals co ...... d promoter region methylation.
@nl
prefLabel
Rapamycin-sensitive signals co ...... d promoter region methylation.
@ast
Rapamycin-sensitive signals co ...... d promoter region methylation.
@en
Rapamycin-sensitive signals co ...... d promoter region methylation.
@nl
P2093
P2860
P50
P356
P1476
Rapamycin-sensitive signals co ...... d promoter region methylation.
@en
P2093
Flore Mietton
Karolina Pilipow
Sara Colombetti
Veronica Basso
P2860
P304
P356
10.1002/EJI.201041130
P407
P577
2011-07-01T00:00:00Z